Clinical Trial Update: To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Envafolimab in combination with XELOX for locally advanced colon cancer; efficacy and safety results are not yet reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Envafolimab (envafolimab)
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Colon Cancer | Phase 2 | Status: UNKNOWN